Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)
NCT00664222
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Chronic Stable Heart Failure
Interventions
DRUG:
spironolactone + furosemide
Sponsor
Tottori University Hospital